Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASII Study: Anti-Staphylococcus aureus ostrich antibody emulsion for atopic dermatitis
jRCTs051240012Active, not recruiting
- Sponsor
- ZEAL COSMETICS Inc.
- Start
- Jun 2024
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Single-arm trial of anti-Staphylococcus aureus ostrich antibody emulsion in atopic dermatitis (AD), sponsored by ZEAL COSMETICS Inc. Primary endpoint: Primary endpoint: Change rate in local EASI score at 4 weeks. Started Jun 2024; status: active, not recruiting.
02
Drugs
anti-Staphylococcus aureus ostrich antibody emulsion
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCTs051240012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240012.